3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Interventions
Temozolomide
18
Radiation
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
6
Specimen Handling
4
Lomustine
4
Bevacizumab
4
Aminolevulinic Acid
3
veliparib
2
trametinib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
Biopsy
2
varlilumab
1
ulixertinib
1
tinostamustine
1
selinexor
1
ruxolitinib
1
ribociclib
1
relatlimab
1
regorafenib
1
peposertib
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Leukapheresis
×
30 days
×
Clear all
No trials found.